Olivari E. Addition of daratumumab to first-line therapy of newly diagnosed multiple myeloma in patients eligible for autologous stem cell transplantation: a single-center real-life experience. Mediterr J Hematol Infect Dis [Internet]. 2025 Apr. 30 [cited 2025 Jul. 15];17(1):e2025040. Available from: https://www.mjhid.org/mjhid/article/view/5995